Berkeley FIT
Berkeley Fit
Company & Technology Intelligence for Biomedicine and Life Sciences

We transform company signals — patents, products, publications — into decision-ready intelligence.

AI-native intelligence products for technology transfer offices, corporate IP teams, investors, and government innovation programs.

Our products
Contact us
The signals behind every company

The Orchestrator Knowledge Graph

Many signals, one unified view — patents, products, publications, clinical trials, and FDA clearances, resolved to the companies behind them, cross-linked, continuously refreshed, and shared by all four products.

165K+
Company profiles
34.2M
Patents & applications
547K+
Commercial products
579K+
Clinical trials
99K+
510(k) clearances
84M
Biomedical publications
40,694
Federal awards
Our Products

Four products on one platform

From a single company to an entire market — each product draws on the same evidence base and shows its work.

Novelty & obviousness1 of 3 novel
Feature 1
Novel
Closest art
US-10408230-B2
Zhao et al., 2009
Feature 2
At risk
Possibly anticipated by
EP-3214291-A1
Nakamura & Ellis, 2016
US-9187203-B1
Feature 3
At risk
Possibly anticipated by
Brandt et al., 2014
WO-2018/104521-A1
Feature 1Novel
Elements
E1
E2
E3
Element vs. reference
StrongModerateLimitedMinimalNot disclosed
E1E2E3US-10408230-B2US-20260027312-A1Zhao et al., 2009Nakamura & Ellis, 2016Brandt et al., 2014Iversen et al., 2021Okonkwo & Reyes, 2018
Refinement interview14 questions
1 / 14Novelty
More details
2 / 14Eligibility

DisclosurePlus™

Know which inventions or disclosures are worth filing — before you spend the money. Pressure test potential inventions against prior art and the statutory requirements.

§ 101 — Eligibility
Whether it's the kind of invention the law lets you patent at all — not an abstract idea or natural phenomenon.
§ 102 — Novelty
Whether it's genuinely new, or already disclosed in the prior art.
§ 103 — Non-obviousness
Whether it's more than an obvious combination of what's already known — the bar most filings fail.
§ 112 — Enablement
Whether the disclosure actually teaches someone skilled in the field how to make and use it.
Draft provisional application
A filing-ready provisional draft, for the inventions worth pursuing.
Full audit trail
Every finding tied to a specific publication and claim element.
See how it works →
Portfolio decisions10 assessed
Decision-ready5
Disclosure
Proceed
US-9687195-B2
Proceed
US-9687195-B2
Proceed
File w/ conditions4
Disclosure
File + narrow
US-20100047344-A1
Narrow claims
Disclosure
File + narrow
Hold0
No reports
Blocked0
No reports
Decline-bound1
Disclosure
Release
US-8587945-B1Caution
4 claims
#
Claim element
Embodiment feature
Disclosure
1
Explicit
2
Explicit
3
—
Partial
4
Partial
5
Explicit

Patent Assessment — PIER™

How strong is your patent? Can you practice it freely? Both questions answered against millions of prior art and commercial products.

Patentability analysis
Novelty, obviousness, eligibility, enablement tested
Freedom-to-operate
Blocking patents named, not just flagged
Prior-art landscape
Closest references and distinctive elements
Clearance table
Per-patent verdict — clear, caution, risky
See how it works →
Company profile
Industries
Health CareMedical Device
Employees
11–50
Membership
510(k)
Contacts
Products
Patents
Ranked search50 companies
Requirement
Affiliation
2
1
1
1
1
View more
Expertise areas
3
2
2
2
View more
RerankedExport
1
2510(k)
3
4
5510(k)
6
7
8
9510(k)
10

Hoover Search

Hoover is the search engine. One canonical profile for every company. AI-native search against the Knowledge Graph. Ask any complex question and get a ranked, evidence-backed shortlist.

Vendor discovery
Identify companies that meet your program's requirements, features, or desired capabilities.
Technology landscape reports
Identify mechanisms of action, patent holders, areas of innovation, and commercial products.
Patent commercialization
Identify potential licensors, licensees, and co-development partners.
Competitive analysis
Identify current and emerging competitors with similar products, patents, or capabilities.
See how it works →
Technology mechanism · M5
Patent filing pace
198 families · median 2014 · 10-yr CAGR −10.3% · 156 assignees
’14’15’16’17’18’19’20’21’22’23’24’25
−10%/yr · last years are publication lag
Top players & fielded systems
Top patent assignees
10
7
6
Commercial sector · S1
Patent clustersC1C2C4C5C6C8
Profiled companies · primary
Also operating · secondary

Technology Landscape Reports

A decision-grade map of an entire field, built to answer your exact questions — every mechanism, company, and patent shaping it — judged and prioritized against your own requirements.

Executive summary
The bottom line and headline calls, up front
Mechanism deep-dives
Each approach scored on maturity and ownership
IP Signal™ analysis
Where is innovation emerging, consolidating, or accelerating.
Regulatory landscape
Market segments and the pathways that gate deployment
Full company profiles
Product vendors, platform providers, all with evidence-backed analysis.
Commercial ecosystem
How is the marketplace organized, who are the dominant players.
See how it works →
Who it's for

Built for decision makers.

Six roles, six decisions — each with a starting point. Find yours below.

Technology transfer office

Which of our invention disclosures are worth filing?

Triage with the rigor you'd give ten, at the volume you actually have.

DisclosurePlus →
Corporate IP team

Can we ship without infringing?

Blocking patents named — not just flagged — with a freedom-to-operate verdict in days.

Patent Assessment →
Outside patent counsel

Why do disclosures land on my desk half-finished?

It arrives complete — gaps closed, novelty mapped — before it hits your desk.

DisclosurePlus →
Procurement and sourcing

What vendors will meet my requirements?

A ranked shortlist with a memo per company — products, patents, regulatory signals compiled.

Hoover →
Investor / Acquiror

How strong is my target's IP portfolio?

Evaluate strength of novelty claims and freedom to operate.

Patent Assessment →
Government Program Office

Across my technology field, who's ahead and what's real?

Every company, product, and patent — judged on maturity and ownership — mapped to your requirements.

Landscape Report →
Confidentiality

Your unpublished inventions stay unpublished.

We never train our model on what you submit. We never share it between customers. You retain all rights. You may delete all your disclosures on demand.

How we handle your data →

Start with the decision in front of you.

One disclosure, one product, one company, or an entire field — we'll show you what the knowledge graph already knows.

Screen a disclosure